| Drug safety data sends Affymax shares tumbling - The Associated Press |
|
|
The Associated PressBut, a subgroup of patients, who were not on dialysis, experienced more heart-related side effects primarily driven by higher rates of death, ...Affymax drops as drug trials raise heart concerns ReutersAffymax Shares Plunge On Hematide Study Data Wall Street JournalAffymax and Takeda Announce Phase 3 Trials Meet Primary Endpoints for ... read more |